Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track LIMN with free AI briefings, catalyst countdowns, and dilution alerts.

LIMN · Liminatus Pharma, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$3M Cash on Hand
6.1mo Cash Runway
Follow LIMN by email Get an email when LIMN reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about LIMN, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

LIMN holds $3M in cash and short-term investments (as of Jun 30, 2026) and burns about $1.5M/quarter from operations, an estimated runway of 6.1 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 63 · High

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LIMN files for a raise →

👥 Who Owns LIMN

Insiders 41.4% Other 5%+ holders 5.1% Institutions (14 holders) 5.5% Public and other holders 48%
HolderTypeShares% of sharesAs of
Iris Acquisition Holdings LLC
10% owner
Insider 6,900,000 10.27% 2025-04-30
Chris Kim
Chief Executive Officer, Director, 10% o
Insider 6,169,406 9.19% 2025-04-30
Ewon Comfortech Co., Ltd.
10% owner
Insider 5,500,000 8.19% 2026-06-24
Valetudo Therapeutics LLC
10% owner · +48,975 options
Insider 5,244,351 7.81% 2026-07-02
KH Feelux Co., Ltd
10% owner
Insider 4,000,000 5.96% 2025-04-30
Samda Biolab Co., Ltd. 5%+ holder (13G) 3,426,548 5.10% 2026-07-02

Share count 67,160,362 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full LIMN picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LIMN and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.